eHealth in Treatment of Gestational Diabetes (eMOMGDM)

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

December 12, 2022

Study Completion Date

December 31, 2026

Conditions
Gestational DiabetesMobile Application
Interventions
DEVICE

eMOM GDM application

"Participants in the intervention group will use the eMOM GDM -application one week/month.~eMOM GDM application includes:~* continuous glucose monitor (CGM, Medtronic)~* diet (digital food tracker) (min 3 days during one application week)~* heartrate, stress and physical activity with the wrist-worn activity tracker (Vivosmart 3)~* weight measured once a week~The sensors can be worn and the application used during the whole pregnancy (if a mother is interested in)"

Trial Locations (1)

00029

Helsinki University Hospital, Helsinki

All Listed Sponsors
collaborator

University of Helsinki

OTHER

collaborator

Aalto University

OTHER

collaborator

UKK Institute

OTHER

collaborator

Tampere University

OTHER

collaborator

Finnish Institute for Health and Welfare

OTHER_GOV

collaborator

Fujitsu

UNKNOWN

collaborator

Elisa Oyj

UNKNOWN

collaborator

Business Finland

OTHER

lead

Helsinki University Central Hospital

OTHER